Engineers Gate Manager LP Zentalis Pharmaceuticals, Inc. Transaction History
Engineers Gate Manager LP
- $4.27 Billion
- Q2 2024
A detailed history of Engineers Gate Manager LP transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 14,637 shares of ZNTL stock, worth $49,033. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,637
Previous 25,612
42.85%
Holding current value
$49,033
Previous $403,000
85.36%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding ZNTL
# of Institutions
148Shares Held
69.8MCall Options Held
61.8KPut Options Held
6.6K-
Matrix Capital Management Company, LP Waltham, MA14MShares$46.8 Million0.43% of portfolio
-
Eventide Asset Management, LLC Boston, MA8.55MShares$28.6 Million0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.65MShares$18.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$16.1 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.5MShares$15.1 Million0.0% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $191M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...